Tag
14 posts tagged “Higher libido”.
A measured, harm-reduction look at enclomiphene, why it is used instead of exogenous testosterone, and the bloodwork that tells you whether it is working.
A cautious, harm-reduction look at cabergoline, why it is used to manage prolactin, and the cardiac risk that has to be taken seriously.
A measured look at mesterolone, a weakly anabolic oral DHT derivative used as an adjunct to lower SHBG and support libido, and what is worth tracking.
A measured, harm-reduction look at testosterone undecanoate in both its very long-ester injectable and oral forms, and the bloodwork that actually matters.
A measured, harm-reduction look at testosterone enanthate, what to monitor on TRT or a cycle, and the bloodwork that actually matters.
Cypionate behaves almost identically to enanthate. Here is what to monitor, the bloodwork that matters, and the mistakes to avoid.
Propionate clears fast, which means frequent injections and sharper fluctuations. Here is what that changes about tracking.
A four-ester testosterone blend with a tricky release curve. Why the mixed esters complicate tracking and what to monitor.
What oxytocin is, how intranasal protocols appear in research, and how to track behavioral effects honestly given how messy the literature is.
How gonadorelin is used alongside TRT and fertility protocols, and what to actually measure.
How to log a kisspeptin-10 protocol focused on reproductive and HPG-axis endpoints.
A measured look at HCG, what it actually does, and the metrics worth tracking.
How to track a Melanotan II loading and maintenance protocol. Dosing patterns, side-effect logging, photos, and the realistic timeline for pigment change.
PT-141 has a distinctive on/off effect profile that needs a different tracking pattern. What to log, when to log it, and the common attribution errors.